Aspira Women's Health Reports Q1 Net Income of $676K, EPS Loss Narrows to ($0.05) Despite Revenue Drop
AWHL has more than doubled off its 52-week low of $0.042 on light trading volume (0.2× avg).
Summary
Aspira Women's Health Inc. reported first-quarter 2026 results, showing a significant improvement in profitability despite a revenue decline. The company posted a net income of $676K, a substantial turnaround from a net loss of ($1.85M) in the prior year quarter, and diluted loss per share narrowed to ($0.05) from ($0.09). This positive shift in net income is particularly material given the company's previously disclosed financial challenges, including a going concern warning and Nasdaq delisting from its last 10-K. While total revenue decreased by 13.7% to $1.97M, primarily due to a drop in OvaSuite test volume, the return to profitability could alleviate immediate concerns about financial viability. Traders will be watching if the company can sustain this profitability and reverse the declining revenue trend.
At the time of this announcement, AWHL was trading at $0.39 on OTC in the Life Sciences sector, with a market capitalization of approximately $17M. The 52-week trading range was $0.04 to $0.71. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.